Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Ed. by Bancalari, Eduardo / Chappelle, Joseph / Chervenak, Frank A. / D'Addario , Vincenzo / Genc, Mehmet R. / Greenough, Anne / Grunebaum, Amos / Konje, Justin C. / Kurjak M.D., Asim / Romero, Roberto / Zalud, MD PhD, Ivica


IMPACT FACTOR 2017: 1.558
5-year IMPACT FACTOR: 1.653

CiteScore 2017: 1.26

SCImago Journal Rank (SJR) 2017: 0.594
Source Normalized Impact per Paper (SNIP) 2017: 0.684

Online
ISSN
1619-3997
See all formats and pricing
More options …
Volume 43, Issue 2

Issues

Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection

Yoko Kobayashi / Ichiro Morioka / Tsubasa Koda / Yuji Nakamachi / Yoko Okazaki / Yoriko Noguchi / Miki Ogi
  • Hyogo Prefectural Institute of Public Health and Consumer Sciences, Infectious Disease Research Division, Kobe, Japan
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Masatsugu Chikahira
  • Hyogo Prefectural Institute of Public Health and Consumer Sciences, Infectious Disease Research Division, Kobe, Japan
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Kenji Tanimura / Yasuhiko Ebina / Toru Funakoshi / Masanobu Ohashi / Kazumoto Iijima / Naoki Inoue
  • National Institute of Infectious Disease, Department of Virology I, Tokyo, Japan; and Department of Microbiology and Immunology, Gifu Pharmaceutical University, Gifu, Japan
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Seiji Kawano / Hideto Yamada
Published Online: 2014-06-26 | DOI: https://doi.org/10.1515/jpm-2014-0071

Abstract

Aims: Neurological outcomes differ considerably between symptomatic and asymptomatic infants with congenital cytomegalovirus (CMV) infection. Our objective was to characterize laboratory markers in symptomatic newborns in comparison with asymptomatic newborns with congenital CMV infection.

Methods: Ten newborns with symptomatic and 13 newborns with asymptomatic congenital CMV infection were included in this 3-year prospective cohort study. Total immunoglobulin M (IgM), CMV-IgM, CMV antigenemia, and CMV-DNA in blood and urine were measured and their positive rates and quantitative values compared between the symptomatic and asymptomatic groups.

Results: Fifty percent of newborns in the symptomatic group were positive based on total IgM; this was significantly lower than in the asymptomatic group (100%). Quantitative total IgM values were significantly lower, and there were significantly more copies of CMV-DNA in the blood of symptomatic newborns than in asymptomatic newborns (median values for total IgM: 14 vs. 43 mg/dL and blood CMV-DNA: 3.2×102 vs. 3.5×101 copies/106 white blood cells). CMV-IgM, CMV antigenemia, and urine CMV-DNA did not differ significantly between groups.

Conclusion: Low total IgM values and high blood CMV loads were associated with the presence of symptoms in newborns with congenital CMV infection.

Keywords: Antigenemia; immunoglobulin; laboratory markers; serology; viral load

References

  • [1]

    Coenraad S, Toll MS, Hoeve HL, Goedegebure A. Auditory brainstem response morphology and analysis in very preterm neonatal intensive care unit infants. Laryngoscope. 2011;121:2245–49.Web of ScienceGoogle Scholar

  • [2]

    Crumpacker CS, Zhang JL. Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010. p. 1971–87.Web of ScienceGoogle Scholar

  • [3]

    Dylewski J, Chou S, Merigan TC. Absence of detectable IgM antibody during cytomegalovirus disease in patients with AIDS. N Engl J Med. 1983;309:493.Google Scholar

  • [4]

    Gondo H, Minematsu T, Harada M, Akashi K, Hayashi S, Taniguchi S, et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol. 1994;86:130–7.Google Scholar

  • [5]

    Griffiths PD, Stagno S, Pass RF, Smith RJ, Alford CA, Jr. Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics. 1982;69:544–9.Google Scholar

  • [6]

    Inoue N, Koyano S. Evaluation of screening tests for congenital cytomegalovirus infection. Pediatr Infect Dis J. 2008;27:182–4.PubMedGoogle Scholar

  • [7]

    Kangro HO, Griffiths PD, Huber TJ, Heath RB. Specific IgM class antibody production following infection with cytomegalovirus. J Med Virol. 1982;10:203–12.CrossrefPubMedGoogle Scholar

  • [8]

    Kawai T, Itoh Y, Hirabayashi Y, Ichihara K, Igarashi S, Iwata S, et al. Establishment of reference intervals and physiological parameters for 13 serum proteins in healthy Japanese adults. Jpn J Clin Pathol. 1996;44:429–34 (in Japanese).Google Scholar

  • [9]

    Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16–25.Google Scholar

  • [10]

    Koyano S, Inoue N, Oka A, Moriuchi H, Asano K, Ito Y, et al. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. Br Med J Open. 2011;1:e000118.Google Scholar

  • [11]

    Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics. 2006;117:e76–83.Google Scholar

  • [12]

    Lazzarotto T, Lanari M. Why is cytomegalovirus the most frequent cause of congenital infection? Expert Rev Anti-Infe. 2011;9:841–3.CrossrefWeb of ScienceGoogle Scholar

  • [13]

    Masuho Y, Matsumoto Y, Sugano T, Fujinaga S, Minamishima Y. Human monoclonal antibodies neutralizing human cytomegalovirus. J Gen Virol. 1987;68:1457–61.Google Scholar

  • [14]

    Matsuo K, Morioka I, Oda M, Kobayashi Y, Nakamachi Y, Kawano S, et al. Quantitative evaluation of ventricular dilatation using computed tomography in infants with congenital cytomegalovirus infection. Brain Dev. 2014;36:10–5.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [15]

    Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making. 1998;18:110–21.CrossrefPubMedGoogle Scholar

  • [16]

    Minematsu T, Hosoda K, Minamishima Y. Evaluation of direct immunoperoxidase technique using F(ab’)2 fractions of anti-cytomegalovirus human monoclonal antibody for enumeration of cytomegalovirus antigen-positive leukocytes. J Jpn Assoc Infect Dis. 1994;68:1278–84 (in Japanese).Google Scholar

  • [17]

    Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol. 1997;24:151–60.PubMedGoogle Scholar

  • [18]

    Nelson CT, Istas AS, Wilkerson MK, Demmler GJ. PCR detection of cytomegalovirus DNA in serum as a diagnostic test for congenital cytomegalovirus infection. J Clin Microbiol. 1995;33:3317–8.PubMedGoogle Scholar

  • [19]

    Noyola DE, Demmler GJ, Nelson CT, Griesser C, Williamson WD, Atkins JT, et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr. 2001;138:325–31.Google Scholar

  • [20]

    Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol. 2006;35:216–20.PubMedCrossrefGoogle Scholar

  • [21]

    Rasmussen L, Kelsall D, Nelson R, Carney W, Hirsch M, Winston D, et al. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis. 1982;145:191–9.Google Scholar

  • [22]

    Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol. 1999;14:57–66.CrossrefPubMedGoogle Scholar

  • [23]

    Schlesinger Y, Halle D, Eidelman AI, Reich D, Dayan D, Rudensky B, et al. Urine polymerase chain reaction as a screening tool for the detection of congenital cytomegalovirus infection. Arch Dis Child Fetal Neonatal Ed. 2003;88:F371–4.CrossrefGoogle Scholar

  • [24]

    Sonoyama A, Ebina Y, Morioka I, Tanimura K, Morizane M, Tairaku S, et al. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection. J Med Virol. 2012;84:1928–33.Web of ScienceCrossrefPubMedGoogle Scholar

  • [25]

    Tanaka Y, Kanda Y, Kami M, Mori S, Hamaki T, Kusumi E, et al. Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation. Bone Marrow Transpl. 2002;30:315–9.CrossrefGoogle Scholar

  • [26]

    Tanaka N, Kimura H, Iida K, Saito Y, Tsuge I, Yoshimi A, et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol. 2000;60:455–62.PubMedCrossrefGoogle Scholar

  • [27]

    Watzinger F, Suda M, Preuner S, Baumgartinger R, Ebner K, Baskova L, et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42:5189–98.PubMedCrossrefGoogle Scholar

  • [28]

    Wong V, Chen WX, Wong KY. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J Child Neurol. 2006;21:309–15.CrossrefGoogle Scholar

  • [29]

    Yagi M, Yamamori M, Morioka I, Yokoyama N, Honda S, Nakamura T, et al. VEGF 936C>T is predictive of threshold retinopathy of prematurity in Japanese infants with gestational age of 30 weeks or less. Res Reports Neonatol. 2011;1:5–11.Google Scholar

  • [30]

    Yolken RH, Leister FJ. Enzyme immunoassays for measurement of cytomegalovirus immunoglobulin M antibody. J Clin Microbiol. 1981;14:427–32.PubMedGoogle Scholar

About the article

Corresponding author: Ichiro Morioka, Department of Pediatrics, Kobe University Hospital 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan, Tel.: +81-78-382-6090, Fax: +81-78-382-6099, E-mail:

aYoko Kobayashi and Ichiro Morioka contributed equally to this work.


Received: 2014-02-26

Accepted: 2014-06-11

Published Online: 2014-06-26

Published in Print: 2015-03-01


Citation Information: Journal of Perinatal Medicine, Volume 43, Issue 2, Pages 239–243, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/jpm-2014-0071.

Export Citation

©2015 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Yasumi Furui, Naoji Yamagishi, Ichiro Morioka, Rikizo Taira, Kosuke Nishida, Shohei Ohyama, Hisayuki Matsumoto, Yuji Nakamachi, Takashi Hasegawa, Keiji Matsubayashi, Tadashi Nagai, and Masahiro Satake
Transfusion, 2018
[2]
Ilija Brizić, Lea Hiršl, William J. Britt, Astrid Krmpotić, and Stipan Jonjić
Microbes and Infection, 2017
[3]
Kosuke Nishida, Ichiro Morioka, Yuji Nakamachi, Yoko Kobayashi, Takamitsu Imanishi, Seiji Kawano, Sota Iwatani, Tsubasa Koda, Masashi Deguchi, Kenji Tanimura, Daisuke Yamashita, Ken-ichi Nibu, Toru Funakoshi, Masanobu Ohashi, Naoki Inoue, Kazumoto Iijima, and Hideto Yamada
Brain and Development, 2016, Volume 38, Number 2, Page 209

Comments (0)

Please log in or register to comment.
Log in